A Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer. — ARTSCANIII

Locally Advanced Head and Neck Cancer Clinical Trial

Official title:
A Randomized Multicenter Phase III Study of Cisplatin Plus Radiotherapy Compared to Cetuximab Plus Radiotherapy in Locally Advanced Head and Neck Cancer.

Status Completed

Clinical Trial Summary

The primary endpoint in this study is to investigate if there is a difference in overall survival in patients with locally advanced head and neck cancer, randomized to either radiotherapy and cetuximab or radiotherapy and cisplatin. A second randomization is performed in patients with T3-T4 tumors; allocated radiotherapy either 68.0 Gy or 73.1 Gy.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Head and Neck Neoplasms
Locally Advanced Head and Neck Cancer

Clinical Trial Details

NCT number	NCT01969877
Study type	Interventional
Source	Lund University Hospital
Contact
Status	Completed
Phase	Phase 3
Start date	November 2013
Completion date	April 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03532737` - Concomitant Immune Check Point Inhibitor With Radiochemotherapy in Head And Neck Cancer	Phase 2
Completed	`NCT03317730` - Pilot Trial of Microsphere Oxycodone (Xtampza ER) for Pain Management in Patients Receiving Radiotherapy for Locally Advanced Head and Neck Cancer	Early Phase 1
Recruiting	`NCT01212354` - Impact of Selective Radiation Dose Escalation and Tumour Hypoxia Status on Locoregional Tumour Control After Radiochemotherapy of HNT	Phase 3
Recruiting	`NCT02976051` - DAHANCA 33: Image Guided Dose-escalated Radiotherapy to Patients With Hypoxic HNSCC	Phase 2
Active, not recruiting	`NCT03699969` - A Study Comparing Hypofractionated Dose Escalated VMAT to Conventional CCRT in Locally Advanced Head and Neck Cancer	N/A